Diabetes mellitus is a major global health issue, with projections estimating 783 million cases by 2045. It increases susceptibility to bacterial infections, with higher frequency and severity compared to non-diabetic individuals. This review explores the "triple threat" of diabetes-associated bacterial infections: altered nutritional availability, immune suppression, and antibiotic resistance. Hyperglycemia, a hallmark of diabetes, promotes bacterial growth and virulence by serving as a nutrient source. Bacteria in diabetic infections form biofilms, enhancing their survival and resistance to antibiotics. Diabetes also impairs immune cell function, reducing the ability to clear pathogens. Immune suppression in diabetes is linked to altered cytokine profiles, impaired phagocytic activity, and reduced free radical production. Additionally, the diabetic infection environment fosters antibiotic resistance, with increased prevalence of multidrug-resistant bacteria. The altered nutrient environment in diabetic infections supports bacterial metabolism and virulence, while immune suppression and antibiotic resistance further worsen outcomes. The review highlights the complex interplay between diabetes and bacterial infections, emphasizing the need for targeted therapies to address these challenges.Diabetes mellitus is a major global health issue, with projections estimating 783 million cases by 2045. It increases susceptibility to bacterial infections, with higher frequency and severity compared to non-diabetic individuals. This review explores the "triple threat" of diabetes-associated bacterial infections: altered nutritional availability, immune suppression, and antibiotic resistance. Hyperglycemia, a hallmark of diabetes, promotes bacterial growth and virulence by serving as a nutrient source. Bacteria in diabetic infections form biofilms, enhancing their survival and resistance to antibiotics. Diabetes also impairs immune cell function, reducing the ability to clear pathogens. Immune suppression in diabetes is linked to altered cytokine profiles, impaired phagocytic activity, and reduced free radical production. Additionally, the diabetic infection environment fosters antibiotic resistance, with increased prevalence of multidrug-resistant bacteria. The altered nutrient environment in diabetic infections supports bacterial metabolism and virulence, while immune suppression and antibiotic resistance further worsen outcomes. The review highlights the complex interplay between diabetes and bacterial infections, emphasizing the need for targeted therapies to address these challenges.